Liver Disease “shrunk” By Blood-pressure Drug

A blood-pressure medicine has been shown to reverse the effects of early-stage liver failure in some patients. Newcastle University researchers analysed a small clinical trial of losartan, a drug normally prescribed for hypertension, on 14 patients in Spain, who had Hepatitis C. The illness was at an advanced stage causing fibrosis - scarring in the liver - which would usually have progressed to liver failure.

More: continued here

Filed under: GastroIntestinal / Gastroentorology on June 4th, 2009